NIHR open research最新文献

{"title":"The SIMCA Study Protocol: Factors influencing the implementation of the Midwifery Continuity of Carer (MCoC) model of care in NHS maternity care in England: A mixed methods cross case analysis involving clinicians, women and policy makers.","authors":"Rebecca Milton, Susan Channon, Julia Sanders, Sara Kenyon, Aimee Middlemiss, Heather Strange, Kate Davies, Lena Choudary-Salter, Susan Barry, Tina Prendeville, Aled Jones","doi":"10.3310/nihropenres.13745.1","DOIUrl":"10.3310/nihropenres.13745.1","url":null,"abstract":"<p><strong>Background: </strong>During pregnancy, labour and early motherhood, most women in the UK receive care from different midwives. The National Health Service (NHS) policy change in England sought to introduce a model of care whereby each woman is cared for by the same midwife throughout antenatal, intrapartum and postnatal periods, supported by a small team of midwives to cover off-duty periods. This model is called the Midwifery Continuity of Carer (MCoC). The aim of this study is proposes to evaluate the implementation and delivery of MCoC across England, aiming to better understand the factors that result in different rates of progress with MCoC implementation.</p><p><strong>Aim: </strong>To identify the local, regional and national factors which contribute to variable progress with implementation of MCoC in the NHS in England?</p><p><strong>Methods: </strong>A sequential mixed-methods study, informed by implementation science frameworks will be delivered over three work packages. Work package 1: Following a literature review of the challenges and successes of previous attempts to implement MCoC. Work package 2: six case studies in NHS Trusts will be undertaken to better understand different rates of progress with MCoC implementation and people's experiences of MCoC implementation through: interview and questionnaire (maternity services staff); interviews (service-users); observation of relevant implementation meetings and organisational documentation collection. Interviews will be undertaken with national and regional stakeholders relevant to MCoC implementation. Work package 3: Data analysis will be conducted both inductively and deductively, informed by implementation science constructs.</p><p><strong>Dissemination: </strong>Study findings will be disseminated through peer-reviewed journals, conferences and events. Results will be of interest to the public, clinical and policy stakeholders in the UK and will be disseminated accordingly.</p>","PeriodicalId":74312,"journal":{"name":"NIHR open research","volume":"5 ","pages":"4"},"PeriodicalIF":0.0,"publicationDate":"2025-04-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11891474/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143598449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacist-led DE-eSCALation of opioids post-surgical dischargE (DESCALE) - A multi-centre, non-randomised, feasibility study protocol.","authors":"Emma L Veale, Johanna Theron, Melanie Rees-Roberts, Julie H Hedayioglu, Ellie Santer, Sabina Hulbert, Vanessa J Short","doi":"10.3310/nihropenres.13716.2","DOIUrl":"10.3310/nihropenres.13716.2","url":null,"abstract":"<p><strong>Background: </strong>Opioids are frequently prescribed for short-term acute pain following surgery. Used appropriately, opioids deliver extremely favourable pain relief. Used longer than 90-days, however, can result in health complications, including unintentional overdose and addiction. Globally, >40 million people are dependent on opioids and annually >100,000 die from opioid misuse. With >4.7 million surgical procedures occurring annually in the United Kingdom it is imperative that opioid-use is managed upon discharge. A declining General Practitioner (GP) workforce and increased patient numbers, however, means gaps in healthcare during transfer of care. Here we report a mixed-methods protocol to understand the feasibility, and acceptability of a clinical pharmacist (CP)-led early opioid deprescribing intervention for discharged surgical patients.</p><p><strong>Methods: </strong>DESCALE is a multicentre, non-randomised, pragmatic feasibility study. Participants aged ≥18 years who have undergone a surgical procedure at a single NHS trust in Southeast England and discharged with opioids and without a history of long-term opioid use, cancer diagnosis or study contraindications will be offered a Medicines Use Review (MUR) within 7-10 days of discharge. The MUR will be delivered by CPs at participating GP practices. Feasibility outcomes will focus on recruitment, fidelity of CPs to deliver the MUR, and barriers within primary care that affect delivery of the intervention, with a maximum sample size of 100. Clinical outcomes will focus on the number of participants that reduce or stop opioid use within 91 days. Prescribing, medical, surgical, and demographic data for individual participants will be collected and analysed to inform future trial design. Qualitative interviews with participants and associated healthcare professionals will explore acceptability and implementation of the intervention.</p><p><strong>Conclusion: </strong>Data collected with respect to opioid use post-surgery, feasibility and acceptability of the intervention, patient experience and outcome data will inform the design of future research and larger clinical trials.</p>","PeriodicalId":74312,"journal":{"name":"NIHR open research","volume":"4 ","pages":"48"},"PeriodicalIF":0.0,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11757927/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143049178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Consumer knowledge of and engagement with traditional takeaway and dark kitchen food outlets.","authors":"Lucie Nield, Helen Martin, Claire Wall, Jo Pearce, Rachel Rundle, Simon Bowles, David Harness, Jordan D Beaumont","doi":"10.3310/nihropenres.13735.2","DOIUrl":"10.3310/nihropenres.13735.2","url":null,"abstract":"<p><strong>Background: </strong>Dark kitchens - delivery-only food outlets operating through digital technology platforms - are a contemporary addition to the food environment. Some concerns have been raised around the ability for local authorities to identify and regulate these businesses, with growing concern around the nutritional quality of foods, food safety practices and impact on the local food environment. The present work explores consumer understanding of and engagement with dark kitchen and traditional takeaway establishments.</p><p><strong>Methods: </strong>Healthy adults living in the United Kingdom completed an online survey comprising of questions measuring demographics, engagement with takeaways and dark kitchens, purchasing behaviours and decision making, and knowledge and understanding around dark kitchens. Data were analysed using descriptive statistics.</p><p><strong>Results: </strong>In total, 2,023 participants (46.3 ± 16.7 years) completed the survey. Forty percent purchased a takeaway at least weekly, often through aggregator applications (e.g., Just Eat, Deliveroo). Food was mainly purchased as a treat (79.3%), for enjoyment of the food or taste (60.8%) and for convenience (58.2%). When ordering, consumers considered the taste (88.1%), quality (83.5%), value for money (77.8%), and familiarity with (68.1%) and reputation of the business (60.0%). Only 24.7% of participants had heard of dark kitchens and 9.1% had knowingly purchased from one. After reading a working definition, 54.9% said they would purchase from a dark kitchen, but most would want to know explicitly that they were ordering from these businesses. A major concern when purchasing food from a dark kitchen or takeaway outlet was trust in the food safety and hygiene standards.</p><p><strong>Conclusion: </strong>Consumers are unfamiliar with dark kitchens and are not aware of or confident in identifying these businesses. This confusion and concerns around food safety mean dark kitchens are often viewed negatively. Consumers would prefer more transparency in where their foods are being prepared to allow for more informed decision-making.</p>","PeriodicalId":74312,"journal":{"name":"NIHR open research","volume":"4 ","pages":"64"},"PeriodicalIF":0.0,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11920686/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143665625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Secure care hospital evaluation of manualised interpersonal art-psychotherapy (SCHEMA): A randomised controlled trial protocol.","authors":"Simon S Hackett, Paula Foscarini-Craggs, Katie Aafjes-van Doorn, Matthew Franklin, Muhammad Riaz, Ania Zubala, Jennifer Condie, Iain McKinnon, Arman Iranpour, Toni Leigh Harrison, Sophie Rose, Elizabeth Randell, Rachel McNamara","doi":"10.3310/nihropenres.13801.1","DOIUrl":"https://doi.org/10.3310/nihropenres.13801.1","url":null,"abstract":"<p><strong>Background: </strong>Within the criminal Justice System in the UK one-third of prisoners self-identified as having a learning difficulty and/or disability. This is broadly consistent with formal assessment of the needs of offenders, with 29% of the offender population having a learning disability. In the UK, NHS and private/independent sector secure care (Forensic) provides assessment and treatment for men and women who have come into contact within the Criminal Justice System and have mental health needs, a personality disorder, and/a learning disability. Patients in these services are often detained under the Mental Health Act (1983) and/or have licence conditions that have been set by the Ministry of Justice.Interpersonal art psychotherapy was developed within secure care as an accessible psychological intervention for adults with mild intellectual disabilities or borderline intellectual functioning. A feasibility randomised controlled trial of interpersonal art psychotherapy showed that assessment of key feasibility objectives were met and the trial procedures were acceptable, indicating progression to a definitive trial.</p><p><strong>Methods: </strong>This is a two-arm single blind randomised controlled trial of effectiveness comparing manualised interpersonal art psychotherapy and Usual Care (UC) to UC. The Randomised Controlled Trial (RCT) will be conducted in a minimum of 10 secure care hospitals (NHS & Independent) with secure care (Forensic) facilities and will recruit 150 participants. The trial design includes an integrated assessment of cost-effectiveness.</p><p><strong>Results: </strong>Individuals with intellectual disabilities and borderline intellectual functioning were involved in the design and set up of the trial. The trial is currently open to recruitment for participants from eight NHS and private/independent secure care sites in the UK.</p><p><strong>Conclusions: </strong>A full report of study results will be published on completion of the trial.</p><p><strong>The trial has been registered: </strong>ISRCTN57406593 ( ISRCTN registry, 2024). This published protocol corresponds with version 6, dated 12.08.2024.</p>","PeriodicalId":74312,"journal":{"name":"NIHR open research","volume":"5 ","pages":"21"},"PeriodicalIF":0.0,"publicationDate":"2025-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12000804/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144060758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Improving follow-up care for people after minor stroke using early personalised care: A protocol for a randomised, mixed-methods, feasibility study.","authors":"Jennifer Crow, Hilary Watt, Mary Wells, Paresh Malhotra","doi":"10.3310/nihropenres.13649.3","DOIUrl":"https://doi.org/10.3310/nihropenres.13649.3","url":null,"abstract":"<p><strong>Background: </strong>Of the 150 000 people per year in the UK who have strokes, third to half will experience a so-called 'minor stroke'. Although appearing benign these strokes put a person at increased risk of further strokes and survivors are usually considered 'too good' for referral onto community stroke services. When back at home the hidden effects of stroke like fatigue and changes in mood and cognition become apparent and impact return to work, relationships and everyday activities. Alongside this, managing the risk of recurrence, highest early after an initial stroke, is a priority. People with stroke report feeling abandoned after discharge with unmet information and support needs.</p><p><strong>Methods: </strong>To address this issue, we reviewed the literature, met with people with stroke and other stakeholders to develop an early, personalised follow-up programme of care for those who currently only receive routine medical follow-up appointments. The design of this complex intervention is informed by the NIHR/MRC framework for complex intervention development and the framework of action described by O'Cathain and colleagues. The intervention is underpinned by self-determination theory. We will be conducting a randomised, mixed methods, single-centre feasibility study to explore the acceptability and feasibility of the intervention. Sixty participants will be recruited from a Hyperacute Stroke Unit and Rapid Assessment Clinic and randomised to the intervention or control group. The intervention group will receive personalised follow-up appointments at two- and six-weeks post-discharge. All participants will have outcome measures taken at baseline and twelve-weeks post-stroke. Patient reported outcomes will be reviewed to assess their suitability for a later definitive trial. Qualitative interviews will be conducted to gain a deeper understanding of life after stroke from those who did and did not receive the intervention.</p><p><strong>Conclusions: </strong>Study findings will be used to further refine the intervention, methods and outcome measurements used. These refinements will inform a future multicentre randomised controlled trial.</p>","PeriodicalId":74312,"journal":{"name":"NIHR open research","volume":"4 ","pages":"44"},"PeriodicalIF":0.0,"publicationDate":"2025-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11868739/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143545045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Severe, uncontrolled epilepsy in pregnancy: A population-based case-control study.","authors":"Bryn Kemp, Andrew Kelso, David Williams, Marian Knight","doi":"10.3310/nihropenres.13743.2","DOIUrl":"10.3310/nihropenres.13743.2","url":null,"abstract":"<p><strong>Background: </strong>Epilepsy affects one percent of the UK population and is the most common serious neurological condition experienced during pregnancy. We compared the characteristics, clinical management, and pregnancy outcomes in women with severe, uncontrolled epilepsy to those of women with well controlled disease.</p><p><strong>Methods: </strong>We conducted a population-based case-control study in all UK consultant-led maternity units. Cases of severe uncontrolled epilepsy during pregnancy were identified prospectively and reported via the UK Obstetric Surveillance System (UKOSS). Severe epilepsy was defined <i>a-priori</i> as ≥1 of the following: admission to hospital during pregnancy to manage seizures; prescribed ≥3 antiepileptic medications; or died from epilepsy. Controls comprised women with epilepsy not meeting the case definition, identified within the same centres as cases. Pre-pregnancy epilepsy control and pregnancy outcomes were compared between groups using multivariable logistic regression.</p><p><strong>Results: </strong>We identified 94 cases between 1 October 2015 and 31 March 2017 and compared these with 186 controls. Cases were significantly more likely to be admitted to manage seizures in the year preceding pregnancy (42/94 cases vs 10/186 controls, adjusted odds ratio [aOR]=7.38 [95% CI 2.70-20.2]), and to report their most recent seizure within 3 months of pregnancy (51/94 cases vs 18/186 controls, aOR=5.86 [95% CI 2.30-15.0]). Cases were significantly more likely to deliver before 37 weeks (20/94 cases vs 8/186 controls, aOR=7.61 [95% CI 2.87-20.2]).</p><p><strong>Conclusions: </strong>Women admitted for seizure management in the year before pregnancy are at higher risk of severe epilepsy during pregnancy and of preterm birth. These women should be prioritised for discussion about pregnancy and contraception. When pregnant, they should be reviewed as early as possible by specialists in the management of epilepsy during pregnancy. Delivering messages about the importance of pregnancy planning and contraception to all women with epilepsy should be viewed as the responsibility of all clinicians involved their care.</p>","PeriodicalId":74312,"journal":{"name":"NIHR open research","volume":"4 ","pages":"53"},"PeriodicalIF":0.0,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11971622/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143797305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"improving Pain mAnagement for childreN and young people attendeD by Ambulance (PANDA): protocol for a realist review.","authors":"Georgie Nicholls, Georgette Eaton, Marishona Ortega, Kacper Sumera, Michael Baliousis, Jessica Hodgson, Despina Laparidou, Aloysius Niroshan Siriwardena, Paul Leighton, Sarah Redsell, Bill Lord, Tatiana Bujor, Gregory Adam Whitley","doi":"10.3310/nihropenres.13627.2","DOIUrl":"10.3310/nihropenres.13627.2","url":null,"abstract":"<p><strong>Background: </strong>Each year in England, 450,000 children and young people (CYP) under 18 years of age are transported by ambulance to emergency departments. Approximately 20% of these suffer acute pain caused by illness or injury. Pain is a highly complex sensory and emotional experience. The intersection between acute pain, unwell CYP and the unpredictable pre-hospital environment is convoluted. Studies have shown that prehospital pain management in CYP is poor, with 61% of those suffering acute pain not achieving effective pain relief (abolition or reduction of pain score by 2 or more out of 10) when attended by ambulance. Consequences of poor acute pain management include altered pain perception, post-traumatic stress disorder and the development of chronic pain. This realist review will aim to understand how ambulance clinicians can provide improved prehospital acute pain management for CYP.</p><p><strong>Methods: </strong>A realist review will be conducted in accordance with the Realist And Meta-narrative Evidence Syntheses: Evolving Standards (RAMESES) guidance. A five-stage approach will be adopted; 1) Developing an Initial Programme Theory (IPT): develop an IPT with key stakeholder input and evidence from informal searching; 2) Searching and screening: conduct a thorough search of relevant research databases and other literature sources and perform screening in duplicate; 3) Relevance and rigour assessment: assess documents for relevance and rigour in duplicate; 4) Extracting and organising data: code relevant data into conceptual \"buckets\" using qualitative data analysis software; and 5) Synthesis and Programme Theory (PT) refinement: utilise a realist logic of analysis to generate context-mechanism-outcome configurations (CMOCs) within and across conceptual \"buckets\", test and refine the IPT into a realist PT.</p><p><strong>Conclusion: </strong>The realist PT will enhance our understanding of what works best to improve acute prehospital pain management in CYP, which will then be tested and refined within a realist evaluation.</p><p><strong>Registration: </strong>PROSPERO Registration: CRD42024505978.</p>","PeriodicalId":74312,"journal":{"name":"NIHR open research","volume":"4 ","pages":"42"},"PeriodicalIF":0.0,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11443194/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142362511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Protocol for the economic evaluation of integrated community-based care compared with integrated facility-based care for HIV, hypertension and diabetes in Tanzania and Uganda (INTE-COMM trial).","authors":"Gerard Joseph Abou Jaoude, Ivan Namakoola, Faith Aikaeli, Godfather Kimaro, Faith Moyo, Francis Xavier Kasujja, Erik Van Widenfelt, Sokoine Kivuyo, Josephine Birungi, Gerald Mutungi, Omary Said Ubuguyu, Stephen Watiti, Kaushik Ramaiya, Sayoki Mfinanga, Moffat Nyirenda, Anupam Garrib, Shabbar Jaffar, Jolene Skordis, Neha Batura","doi":"10.3310/nihropenres.13794.2","DOIUrl":"10.3310/nihropenres.13794.2","url":null,"abstract":"<p><strong>Background: </strong>The number of people living with multiple chronic conditions in sub-Saharan Africa is increasing, but health facilities are unable to meet demand. To improve health system capacity and access to care, community models of HIV care have been trialled in countries such as Tanzania and Uganda. However, no evidence exists to inform policymakers on the effectiveness and cost-effectiveness of integrated community-based models of care for HIV and chronic non-communicable conditions. This protocol outlines a within-trial economic evaluation to address this gap.</p><p><strong>Methods & analysis: </strong>We will estimate the costs and cost-effectiveness of integrated community-based care for HIV, hypertension and diabetes compared with facility-based care within the INTE-COMM pragmatic cluster-randomised trial in Tanzania and Uganda. Analyses will adopt a 52-week time horizon, the duration of trial follow-up. The full enrolled trial sample will be analysed from a societal perspective, comprising provider and patient perspectives. Economic costs will be estimated, which includes valuing inputs such as donated goods or time foregone by participants because of receiving care. For provider costs, participant case report forms will inform resource use along with data from facilities and community sites. Resources will be valued using project accounts, facility spending, and locally available cost data. Patient costs will be estimated based on a care-seeking and cost questionnaire administered to participants. Estimated costs will be analysed with co-primary trial outcomes on plasma viral load suppression, glycaemia and blood pressure control to calculate incremental cost-effectiveness ratios (ICER). We will also calculate ICERs for secondary trial outcomes related to health-related quality of life and wellbeing. Cost drivers and outcomes will be varied within confidence bounds in a two-way sensitivity analysis. We will investigate equity impact by estimating the mean difference in outcomes between integrated community-based and facility-based care across household socio-economic quintiles and by measuring whether participants incurred catastrophic health expenditures.</p><p><strong>Trial registration number: </strong>The ISRCTN Registry: ISRCTN15319595. Registered on 07 June 2022: https://doi.org/10.1186/ISRCTN15319595.</p>","PeriodicalId":74312,"journal":{"name":"NIHR open research","volume":"4 ","pages":"80"},"PeriodicalIF":0.0,"publicationDate":"2025-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11868744/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143545121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mapping decision-making pathways: Determination of intervention entry points for diagnostic tests in suspected serious infection.","authors":"Raasti Naseem, Nicola Howe, Sara Pretorius, Cameron Williams, Clare Lendrem, Philip Pallmann, Enitan D Carrol","doi":"10.3310/nihropenres.13568.2","DOIUrl":"10.3310/nihropenres.13568.2","url":null,"abstract":"<p><strong>Background: </strong>PROTECT ( Platform Randomised evaluation of clinical Outcomes using novel TEChnologies to optimise antimicrobial Therapy) has brought together a team of researchers to design a platform trial to rapidly evaluate and adopt into care multiple diagnostic technologies, bringing immediate benefit to patients. Rapid diagnostic tests will be used to identify patients at risk of deterioration from severe infection, before they become critically unwell. The platform will assess their comparative clinical effectiveness and cost-effectiveness relative to current standard of care. Preliminary work, conducted under a Health Technology Assessment Application Acceleration Award, provided key evidence to optimise the design of the PROTECT platform.</p><p><strong>Methods: </strong>Qualitative methods which involved consulting key stakeholders in the field of serious infection addressed the key priorities. A high-level care pathway analysis focusing on serious infection in secondary care, captured the points of contact, actions, decisions, and potential outcomes associated with a patient's care.</p><p><strong>Results: </strong>Two use cases of rapid diagnostic tests for serious infection were identified; (1) in acute emergency medicine to decide on antimicrobial initiation and/or escalation of care, and (2) in hospitalised patients to monitor treatment response. The \"ideal\" test should be rapid, point-of-care, cheap to procure, have capacity for high usability, and ability to be performed and interpreted by all staff. Facilitators to the adoption of infection diagnostic tests is their clinical need, and the main potential barrier is poor change management and behavioural change.</p><p><strong>Conclusions: </strong>Any new test should provide robust evidence of its clinical effectiveness and have the potential to accelerate ruling in or out serious infection which benefits the clinical pathway for patients, clinicians, and hospitals as a whole, to be considered for adoption as a new standard of care.</p>","PeriodicalId":74312,"journal":{"name":"NIHR open research","volume":"4 ","pages":"35"},"PeriodicalIF":0.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11754954/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143030379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Eczema Bathing Study: Weekly versus daily bathing for people with eczema? Protocol of an online, randomised controlled trial.","authors":"Wei Chern Gavin Fong, Laura Howells, Ingrid Muller, Eleanor J Mitchell, Arabella Baker, Leila Thuma, Eleanor Harrison, Lucy Bradshaw, Yimin Jiang, Fiona Cowdel, Paul Leighton, Alan Montgomery, Jane Ravenscroft, Matthew J Ridd, Miriam Santer, Reiko J Tanaka, Nicholas Hilken, Richard Swinden, Richard Dooley, Carron Layfield, Clare Upton, Sophia Collins, Firoza Davies, Tracy Owen, Mars Eddis-Finbow, Devin Patel, Goldie Putrym, Hywel C Williams, Amanda Roberts, Kim S Thomas","doi":"10.3310/nihropenres.13659.1","DOIUrl":"10.3310/nihropenres.13659.1","url":null,"abstract":"<p><strong>Background: </strong>A priority setting partnership for eczema (syn atopic eczema, atopic dermatitis) has identified that bathing frequency is a key area of patient interest. However, there are nolarge, high-quality randomised controlled trials (RCTs) investigating this.The Rapid Eczema Trials project is a novel programme of research that aims to deliver multiple online RCTs, using a citizen science approach. This project involves working with members of the public to co-design and conduct studies that answer questions of importance to them. The first trial to be conducted through this project is assessing the impact of bathing frequency on eczema.</p><p><strong>Methods: </strong>This is an online, two-arm, parallel-group superiority RCT with internal pilot phase. People aged ≥1 year with eczemaliving in the United Kingdom are eligible. Exclusion criteria are: people with other types of eczema such as venous eczema, hand eczema and contact eczema; recently started a new eczema treatment; taking part in another eczema trial; Patient Oriented Eczema Measure (POEM) ≤2; planning to swim more than twice a week; unable/unwilling to change bathing practices. Participants are allocated 1:1 to either the weekly bathing group (bathe 1 or 2 times a week) or the daily bathing group (bathe 6 or more times a week) for 4 weeks. The primary outcome is POEM, assessed weekly over 4 weeks. Secondary outcomes include skin specific quality of life, eczema control, itch severity, use of usual eczema treatments, proportion who achieve an improvement in POEM of ≥3 points, global change in eczema and safety outcomes. A sample of participants will also be invited to a semi-structured interview to discuss their experience. The primary comparative analysis will be according to randomised allocation regardless of actual frequency of bathing. The trial will be reported in accordance with CONSORT guidelines. The study has received ethical approval by the London - Surrey Research Ethics Committee (2 Redman Place, London, E20 1JQ, United Kingdom) on 11/10/2023 ( approval number: 23/PR/0899).</p><p><strong>Trial registration: </strong>ISRCTN12016473, 22/11/2023, https://doi.org/10.1186/ISRCTN12016473.</p>","PeriodicalId":74312,"journal":{"name":"NIHR open research","volume":"4 ","pages":"63"},"PeriodicalIF":0.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11803374/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}